fbpx

Press Releases

Cellaviva Sverige January 31, 2019

Iterim report quarter 1

First quarter (2018-09-01 till 2018-11-30) Net sales amounted to SEK 73,745 (158,354). Apart from the accrual effect, sales increased by 7 %. Operating result amounted to SEK -5,440,809 (-3,210,815).                         Earnings…

Cellaviva Sverige January 30, 2019

Patients treated with ProTrans in phase II of the clinical trial

NextCell Pharma AB (“NextCell”) hereby announces that they today have reached a significant milestone as they have now initiated the second part of the ProTrans-1 clinical trial. In addition to…

Cellaviva Sverige December 5, 2018

NextCell strengthens the organization for continued growth

NextCell Pharma AB (“NextCell”) hereby announces that the Board has decided to appoint Sofia Fredrikson to CFO in the company. Sofia Fredrikson will take office starting today. Former CFO, Leo…

Cellaviva Sverige November 28, 2018

NextCell CEO invited speaker at Karolinska Institutet Conference

NextCell Pharma AB (“NXTCL”) announces that its CEO, Mathias Svahn PhD has been invited to speak at the Karolinska Institutet conference “From tissue to motion” – a 10-year anniversary. The…

Cellaviva Sverige November 16, 2018

ProTrans trial is approved for high dose treatment in the phase II part

The stem cell company NextCell Pharma AB (“NXTCL”) today announced that the Swedish Medical Product Agency has approved the amendment for treatment of patients in the ProTrans-1 trial with high…

Cellaviva Sverige November 14, 2018

NextCell Pharma's clinical trial on the TV3 Diabetes gala

Stem cell company NextCell Pharma AB (“NXTCL”) announces that the ongoing clinical trial with ProTrans for the treatment of type 1 diabetes, tonight will be highlighted on the Diabetes Gala….

Cellaviva Sverige November 12, 2018

Earlier announced directed share issue to Nordic Tech House AB registered at the Swedish Companies Registrations Office

NextCell Pharma AB (“NextCell”) hereby announces that the directed share issue to Nordic Tech House AB (”NTH”) has been registered at the Swedish Companies Registrations Office (Bolagsverket). The newly issued…

Cellaviva Sverige November 9, 2018

Publication of annual report 2017/2018

NextCell Pharma AB hereby, on November 9th, 2018, publishes the annual report for the fiscal year 2017/2018. The annual report is available on the company’s website (www.nextcellpharma.com) and Spotlight Stock…